Synapse - Global Drug Intelligence Database

Overview

Tags

Neoplasms

Hemic and Lymphatic Diseases

Skin and Musculoskeletal Diseases

Small molecule drug

Synthetic peptide

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Neoplasms	2
Hemic and Lymphatic Diseases	1
Immune System Diseases	1

Top 5 Drug Type	Count

Small molecule drug	1
Unknown	1
Synthetic peptide	1

Top 5 Target	Count

αvβ3 x αvβ5	1

This study looks at the quality of the common mechanisms used to diagnose obstructive sleep apnoea (OSA) by patients in their own homes. These are pulse oximetry as a stand alone measurement and multi-channel respiratory studies that measure oximetry but also record some combination of signals including airflow at the mouth and or nose, chest and abdominal expansion, body position and snoring. This study will examine the patient acceptability of these methods and the proportion of studies that achieve various levels of technical quality ranging from a full night with all data available to a completely failed study and categories in between.

Start Date04 May 2022

Sponsor / Collaborator

Papworth Hospital Nhs Foundation Trust Charity

[+1]

100 Clinical Results associated with Iceni Pharmaceuticals Ltd

Login to view more data

0 Patents (Medical) associated with Iceni Pharmaceuticals Ltd

Login to view more data

100 Deals associated with Iceni Pharmaceuticals Ltd

Login to view more data

100 Translational Medicine associated with Iceni Pharmaceuticals Ltd

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 10 Mar 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Early Phase 1

2

1

Phase 2

Other

2

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Cilengitide ( αvβ3 x αvβ5 )	Multiple Myeloma More	Phase 1/2
ICE3 (Iceni Pharmaceuticals)	Breast Cancer More	Early Phase 1
BDNA-003	Chlamydia Infections More	Discontinued
Hepatitis B vaccine (BigDNA) ( HBV capsid )	Hepatitis B More	Discontinued